Determinant of Depression in Multi - Drug Resistant Tuberculosis (MDR) at Waled Cirebon Regional General Hospital
https://doi.org/10.33860/jik.v19i2.4225
Keywords:
MDR-TB, depression, comorbidity, social support, IndonesiaAbstract
Depression is a common psychological complication among patients with multidrug-resistant tuberculosis (MDR-TB), affecting treatment adherence and recovery outcomes. Identifying the determinants of depression in this population is essential for developing comprehensive care strategies. This cross-sectional study was conducted among 28 MDR-TB patients at RSUD Waled. Data on demographic, clinical, and psychosocial variables were collected through structured questionnaires. Depression was assessed using a standardized screening tool. Bivariate analysis was performed using chi-square tests, followed by multivariate logistic regression to identify independent predictors of depression. The bivariate analysis showed no significant association between age (p=0.063), gender (p=0.07), income (p=0.065), or educational attainment (p=0.63) with depression, indicating that these demographic and socioeconomic factors did not influence depressive outcomes. In contrast, comorbidities (p<0.001), duration of illness (p=0.011), and community stigma (p<0.001) were significantly associated with depression. Respondents with comorbidities, longer illness duration, and negative community stigma were markedly more likely to experience depression, suggesting that clinical and psychosocial factors are stronger determinants than demographic variables. Comorbidities, longer illness duration, and community stigma were significantly related to depressive outcomes. Future research with larger and more diverse populations is needed to validate these findings and explore contextual factors influencing depression in MDR-TB patients.
References
1. Global Tuberculosis Report 2023 [Internet]. [cited 2025 Jul 23]. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2023
2. Indonesia’s Movement to End TB [Internet]. [cited 2025 Jul 23]. Available from: https://kemkes.go.id/eng/indonesias-movement-to-end-tb
3. Tuberculosis [Internet]. [cited 2025 Jul 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
4. Chand SP, Arif H. Depression. StatPearls [Internet]. 2023 Jul 17 [cited 2025 Jul 23]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK430847/
5. Panibatla V, Nagaraja SB, Mohan D, Kizhakkethil SMP, Sangeetha MD. Depression and Anxiety among Tuberculosis Patients: A Systematic Review and Meta-analysis. Indian J Soc Psychiatry. 2024;40(4):326–40. Available from: https://journals.lww.com/ijsp/fulltext/2024/40040/depression_and_anxiety_among_tuberculosis.2.aspx
6. Ambaw F, Mayston R, Hanlon C, Medhin G, Alem A. Untreated depression and tuberculosis treatment outcomes, quality of life and disability, Ethiopia. Bull World Health Organ. 2018 Apr 1;96(4):243–55. Available from: https://pubmed.ncbi.nlm.nih.gov/29695881/
7. Walker IF, Khan AM, Khan AM, Khan NM, Ayub RM, Ghias KN, et al. Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study. The International Journal of Tuberculosis and Lung Disease. 2018;22(7):773–8. Available from: http://dx.doi.org/10.5588/ijtld.17.0788
8. Susanto TD, Widysanto A, Cipta DA, Tanara A, Wirawan GR, Kosim AB, et al. Anxiety and depression level of patients with multidrug-resistant tuberculosis (MDR-TB) in two hospitals in Banten province, Indonesia. Dialogues in Health. 2023;2:100115. Available from: http://dx.doi.org/10.1016/j.dialog.2023.100115
9. Mendoza-Torres JC, Durán-Hernández N, Choreño-Parra JA, Sánchez-Garibay C, Salinas-Lara C. Hippocampal syndrome secondary to tuberculosis: From neuroinflammation to neurodegeneration. Tuberculosis. 2025 Jul 1;153. https://pubmed.ncbi.nlm.nih.gov/40446382/
10. Samal J, Dehury RK, Thomas MB, Singh H. Prevalence and predictors of depression in tuberculosis patients in india: a systematic review and meta-analysis. Discover Mental Health. 2025 Dec 1;5(1):104. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC12255643/
11. Tuberculosis resurges as top infectious disease killer [Internet]. [cited 2025 Jul 23]. Available from: https://www.who.int/news/item/29-10-2024-tuberculosis-resurges-as-top-infectious-disease-killer
12. Wang X bo, Li X lian, Zhang Q, Zhang J, Chen H yan, Xu W yuan, et al. A Survey of Anxiety and Depressive Symptoms in Pulmonary Tuberculosis Patients With and Without Tracheobronchial Tuberculosis. Front Psychiatry. 2018;9. Available from: http://dx.doi.org/10.3389/fpsyt.2018.00308
13. Dong X, Zhao L, Sun T, Yun F, Qiu L. Prevalence of Depressive Symptoms and Associated Factors among Internal Migrants with Tuberculosis: A Cross-Sectional Study in China. Am J Trop Med Hyg. 2020;102(1):31–5. Available from: http://dx.doi.org/10.4269/ajtmh.19-0542
14. Gong Y, Yan S, Qiu L, Zhang S, Lu Z, Tong Y, et al. Prevalence of Depressive Symptoms and Related Risk Factors among Patients with Tuberculosis in China: A Multistage Cross-Sectional Study. Am J Trop Med Hyg. 2018;98(6):1624–8. Available from: http://dx.doi.org/10.4269/ajtmh.17-0840
15. Javaid A, Mehreen S, Khan MA, Ashiq N, Ihtesham M. Depression and its Associated Factors with Multidrug-Resistant Tuberculosis at Baseline. J Depress Anxiety. 2017;06(01). Available from: https://www.longdom.org/open-access/depression-and-its-associated-factors-with-multidrugresistant-tuberculosis-at-baseline-30558.html
16. Patel M, Patel N. Exploring Research Methodology: Review Article. International Journal of Research & Review. 2019 Mar;6(3):48–55. Available from: https://www.ijrrjournal.com/IJRR_Vol.6_Issue.3_March2019/Abstract_IJRR0011.html
17. Subhaktiyasa PG. Menentukan Populasi dan Sampel: Pendekatan Metodologi Penelitian Kuantitatif dan Kualitatif. Jurnal Ilmiah Profesi Pendidikan. 2024;9(4):2721–31. Available from: http://dx.doi.org/10.29303/jipp.v9i4.2657
18. Duko B, Bedaso A, Ayano G. The prevalence of depression among patients with tuberculosis: a systematic review and meta-analysis. Ann Gen Psychiatry [Internet]. 2020;19(1). Available from: http://dx.doi.org/10.1186/s12991-020-00281-8
19. Stanikzai MH, Ishaq N, Zafar MN, Baray AH, Anwary Z, Ahmad M, et al. Depression symptoms among Afghan TB patients: A multi-center study. Indian Journal of Tuberculosis. 2024 Jan 1;71:S264–8. https://pubmed.ncbi.nlm.nih.gov/39370194/
20. Stanikzai MH, Wafa MH, Baray AH, Rahimi AF, Sayam H. Anti-TB treatment non-adherence predictors: A multi-center cross-sectional study in Kandahar, Afghanistan. Indian Journal of Tuberculosis. 2025 Jul 1;72(3):298–303. https://pubmed.ncbi.nlm.nih.gov/40707079/
21. Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients. Tuberc Res Treat. 2013;2013:489865. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3649695/
22. Ambaw F, Mayston R, Hanlon C, Alem A. Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia. BMC Psychiatry. 2017;17(1). Available from: http://dx.doi.org/10.1186/s12888-017-1231-4
23. Suratmini D, Berliana Togatorop L. Hubungan Stigma Dan Efikasi Diri Dengan Kepatuhan Pengobatan Obat Anti Tuberkulosis (OAT) Pasien Tuberkulosis: Literatur Review. Jurnal Keperawatan Widya Gantari Indonesia. 2023 Jul 12;7(2). https://ejournal.upnvj.ac.id/Gantari/article/view/5736
24. Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, et al. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient’s perspective. The International Journal of Tuberculosis and Lung Disease. 2013;17(7):954–60. Available from: http://dx.doi.org/10.5588/ijtld.12.0480
25. Paul R, Muhammad T, Rashmi R, Sharma P, Srivastava S, Zanwar PP. Depression by gender and associated factors among older adults in India: implications for age-friendly policies. Sci Rep. 2023 Dec 1;13(1):17651. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10582097/
26. Epriliani, P., Candra IW. Mindfullness-Based Cognitive Therapy ( MCBT ) Menurunkan Tingkat Depresi. Jurnal Gema Keperawatan. 2019;12(2). https://ejournal.poltekkes-denpasar.ac.id/index.php/JGK/article/view/1031
27. Shevchenko OS, Todoriko LD, Synenko TO, Kiba VP, Pohorielova OO, Pidverbetska OV. Tuberculosis Diagnosis with Rapid Molecular Tests of Stool Samples in Adults with Severe Mental Illness (Review). Tuberculosis, Lung Diseases, HIV Infection. 2025 Jul 29;(3):100–6. http://tubvil.com.ua/article/view/336304
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
